Tesla had a remarkable trading session on April 15, 2026, as its stock surged by 7.6% to close at $392.04. This impressive gain is part of a broader week-long rally, with the shares rising 14.2% over the past seven days.
The broader market also contributed to Tesla’s upward momentum, as the S&P 500 climbed 0.2% and the Nasdaq Composite increased by 0.5%. Investor sentiment was buoyed by hopes for a potential resolution to the ongoing Iran conflict, which has been a focal point for market movements.
Tesla just taped out the AI5 chip, huge milestone for FSD, Robotaxi & Optimus.
• Single AI5 delivers ~5x the real-world compute of a dual AI4 setup
• Massive leaps: ~8x compute power, 9x memory & 5x bandwidth vs current gen
• One chip matches Nvidia H100 performance for… pic.twitter.com/1ig6jrBvpw
— DogeDesigner (@cb_doge) April 15, 2026
However, the real story came from within Tesla itself.
Elon Musk took to social media to announce that the company’s AI chip design team has completed the “tape out” of the much-anticipated AI5 self-driving chip. Musk referred to this as a critical milestone as the chip moves into manufacturing. He expressed gratitude towards Samsung and TSMC for their roles in the production phase.
Musk revealed that the AI5 aims to become “one of the most produced AI chips ever,” with high-volume production expected to begin in 2027. This chip is designed to eventually supplant the current AI4 chips in Tesla vehicles. Excitingly, Musk hinted at a potential tape-out for the next-generation AI6 chip as early as December 2026.
Wall Street Perspective
Despite these optimistic developments, not all analysts are rushing to endorse Tesla’s stock swiftly.
Barclays analyst Dan Levy maintained an Equalweight rating with a price target of $360. He pointed out that Tesla’s fourth-quarter results indicate the phasing out of Model S and Model X production, signifying a strategic shift toward what Musk calls “Physical AI.” Levy elaborated on Tesla’s ambitious plans for a proposed “Terafab” facility, which would harness 1 terawatt of AI computing capacity, a figure approximately 50 times the current global capacity. However, he warned about limited visible progress on projects, including Robotaxi and the Optimus humanoid robot initiative.
Contrastingly, UBS took a more favorable stance. Analyst Joseph Spak upgraded Tesla from Sell to Hold, with a price target of $352. He noted that the current price levels more effectively balance the near-term risks while cautioning that the stock may remain volatile, influenced more by sentiment than by underlying fundamentals.
UBS projects that Tesla will deliver approximately 1.6 million vehicles in 2026, remaining relatively flat compared to previous years, with an anticipated 7% compound annual growth rate projecting it to about 2 million units by 2030, trailing behind market estimates of roughly 3 million.
Valuation Challenges Persist
Despite the recent rally, Tesla’s valuation remains a topic of discussion. Currently, the company sports a P/E ratio of 363x based on trailing twelve-month figures, significantly overshadowing its five-year median of 107.4x. GuruFocus indicates a fair value of $254.36 for the stock, marking a 54% premium over current prices.
Adding to this narrative, insider transactions have revealed a trend over the past three months, with insiders selling $20.9 million worth of stock without offsetting purchases, raising eyebrows among investors concerned about confidence levels within the company.
Year-to-date, Tesla’s stock remains down 19%, contrasting sharply with the S&P 500’s nominal 2% gain within the same timeframe.
